The Kinetics of Integrilin Limited by Obesity: A multicenter randomized pharmacokinetic and pharmacodynamic clinical trial
John P. Vavalle(Clinical Research Institute), John H. Alexander(Ohio State University Hospital), Susanna R. Stevens(Mayo Clinic), David E. Kandzari(Piedmont Atlanta Hospital), Anita Arnold(St Bartholomew's Hospital), Frank V. Aguirre(St. John's Hospital), Mauricio G. Cohen(Santa Ana College), Nancy Hassinger(St. Mary's Medical Center), Daniel D. Gretler(Portola Pharmaceuticals (United States))
Cited by 5
Related Papers
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
|Journal of the American College of Cardiology|2021|1.5k